These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 9060817)

  • 21. The distinction of Hodgkin's disease from B cell lymphoma.
    Warnke RA
    Semin Diagn Pathol; 1992 Nov; 9(4):284-90. PubMed ID: 1480850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent lymphocyte predominance Hodgkin's disease and T-cell lymphoma. A report of three cases.
    Delabie J; Greiner TC; Chan WC; Weisenburger DD
    Am J Surg Pathol; 1996 Mar; 20(3):355-62. PubMed ID: 8772790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous lymphocyte predominant Hodgkin's disease and large-cell lymphoma.
    Grossman DM; Hanson CA; Schnitzer B
    Am J Surg Pathol; 1991 Jul; 15(7):668-76. PubMed ID: 2058762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
    Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
    Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hodgkin's disease-like lymphoproliferative disorders in patients with different underlying immunodeficiency states.
    Tinguely M; Vonlanthen R; Müller E; Dommann-Scherrer CC; Schneider J; Laissue JA; Borisch B
    Mod Pathol; 1998 Apr; 11(4):307-12. PubMed ID: 9578079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
    Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
    Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hodgkin's disease, lymphocyte-predominant type: immunoreactivity with B-cell antibodies.
    Coles FB; Cartun RW; Pastuszak WT
    Mod Pathol; 1988 Jul; 1(4):274-8. PubMed ID: 3266337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hodgkin's disease presenting as a solitary bone tumor. A report of four cases and review of the literature.
    Ozdemirli M; Mankin HJ; Aisenberg AC; Harris NL
    Cancer; 1996 Jan; 77(1):79-88. PubMed ID: 8630944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
    Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
    Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
    Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
    Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Nodular lymphocyte predominance Hodgkin's disease and its differential diagnosis].
    Carbonnelle A; Delarue R; Canioni D; Brousse N
    Ann Pathol; 2004 Apr; 24(2):136-48; quiz 135. PubMed ID: 15220833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.
    Ko YH; Kim CW; Park CS; Jang HK; Lee SS; Kim SH; Ree HJ; Lee JD; Kim SW; Huh JR
    Cancer; 1998 Aug; 83(4):806-12. PubMed ID: 9708949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphocyte predominant Hodgkin's disease--a workshop report. European Task Force on Lymphoma.
    Sextro M; Diehl V; Franklin J; Hansmann ML; Anagnostopoulos I; Marafioti T; Stein H
    Ann Oncol; 1996; 7 Suppl 4():61-5. PubMed ID: 8836412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte predominant Hodgkin's disease.
    Ekstrand BC; Horning SJ
    Curr Oncol Rep; 2002 Sep; 4(5):424-33. PubMed ID: 12162918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study.
    Asano N; Oshiro A; Matsuo K; Kagami Y; Ishida F; Suzuki R; Kinoshita T; Shimoyama Y; Tamaru J; Yoshino T; Kitamura K; Fukutani H; Morishima Y; Nakamura S
    J Clin Oncol; 2006 Oct; 24(28):4626-33. PubMed ID: 16954517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.
    Bodis S; Kraus MD; Pinkus G; Silver B; Kadin ME; Canellos GP; Shulman LN; Tarbell NJ; Mauch PM
    J Clin Oncol; 1997 Sep; 15(9):3060-6. PubMed ID: 9294468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The interface of Hodgkin's disease and anaplastic large cell lymphoma.
    Chittal SM; Delsol G
    Cancer Surv; 1997; 30():87-105. PubMed ID: 9547988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extranodal lymphocyte predominance Hodgkin's disease. Clinical and pathologic features.
    Siebert JD; Stuckey JH; Kurtin PJ; Banks PM
    Am J Clin Pathol; 1995 Apr; 103(4):485-91. PubMed ID: 7726148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathology of Hodgkin's lymphoma.
    Eberle FC; Mani H; Jaffe ES
    Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.